We are live on
!
Find out more
AstraZeneca
AZN
AZN
1,229 hedge funds and large institutions have $39.1B invested in AstraZeneca in 2024 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 496 increasing their positions, 396 reducing their positions, and 88 closing their positions.
New
Increased
Maintained
Reduced
Closed
45% more call options, than puts
Call options by funds: $485M | Put options by funds: $334M
33% more first-time investments, than exits
New positions opened: 117 | Existing positions closed: 88
25% more repeat investments, than reductions
Existing positions increased: 496 | Existing positions reduced: 396
2% more funds holding
Funds holding: 1,210 → 1,229 (+19)
0% more capital invested
Capital invested by funds: $39B → $39.1B (+$45.6M)
0.03% more ownership
Funds ownership: 16.11% → 16.15% (+0.03%)
11% less funds holding in top 10
Funds holding in top 10: 19 → 17 (-2)
Holders
1,229
Holders Change
+19
Holders Change %
+1.57%
% of All Funds
17.65%
Holding in Top 10
17
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-10.53%
% of All Funds
0.24%
New
117
Increased
496
Reduced
396
Closed
88
Calls
$485M
Puts
$334M
Net Calls
+$152M
Net Calls Change
-$13M
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$808M |
| 2 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$200M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$130M |
| 4 |
D.E. Shaw & Co
New York
|
+$126M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$123M |
